Vantia Limited
Records under this name other than patents Vantia Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,234,939 | Dosage Forms Comprising a Plasma Kallikrein Inhibitor Formerly held In force · High confidence | In force | High confidence | |
| US 7,649,000 | Selective Dipeptide Inhibitors of Kallikrein Formerly held Term ended Term ended Oct 11, 2025 · High confidence | Term ended | Term ended Oct 11, 2025 | High confidence |
| US 8,202,858 | Vasopressin V1a antagonists Lapsed on the fee record Ended Jun 19, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 19, 2024 | From the USPTO record |
| US 9,145,397 | Process for the preparation of 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl) benzylcarbamoyl)-L-proline-N, N-dimethylamide Lapsed on the fee record Ended Sep 29, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 29, 2023 | From the USPTO record |
| US 9,079,881 | Polymorph of 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline-N,N-dimethylamide Lapsed on the fee record Ended Jul 14, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 14, 2023 | From the USPTO record |
| US 9,073,928 | Tosylate salt of cyclopropanecarboxylic acid 4-(6-chloro-3-methyl-4, 10-dihydro-3H-2,3,4,9-tetrabenzo[f]azulene-9-carbonyl)-2-fluorobenzylamide Lapsed on the fee record Ended Jul 7, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 7, 2023 | From the USPTO record |
| US 7,074,781 | Condensed azepines as vasopressin agonists Term ended Term ended Feb 22, 2022 · From the USPTO record | Term ended | Term ended Feb 22, 2022 | From the USPTO record |
| US 7,560,454 | Condensed azepines as vasopressin agonists Term ended Term ended Jan 4, 2021 · From the USPTO record | Term ended | Term ended Jan 4, 2021 | From the USPTO record |
| US 8,183,280 | FAP inhibitors Lapsed on the fee record Ended May 22, 2016 · From the USPTO record | Lapsed on the fee record | Ended May 22, 2016 | From the USPTO record |
| US 6,096,712 | Kininogen inhibitors Term ended Term ended May 16, 2016 · From the USPTO record | Term ended | Term ended May 16, 2016 | From the USPTO record |